Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/23/2026 | Q4 | $416.6M | -- | -- | $2.71 | -- |
| 11/06/2025 | Q3 | $366.4M | $363.7M | -$0.09 | $1.78 | -$1.87 |
| 08/07/2025 | Q2 | $338.2M | $352.2M | $0.62 | $1.19 | -$0.56 |
| 05/08/2025 | Q1 | $322.8M | $328.6M | $0.56 | $1.25 | -$0.68 |
| 02/24/2025 | Q4 | $424.4M | $412.8M | $1.37 | $2.63 | -$1.26 |
| 11/07/2024 | Q3 | $348M | $353.6M | -$1.11 | $1.51 | -$2.61 |
| 08/07/2024 | Q2 | $333M | $320.8M | $0.77 | $1.26 | -$0.49 |
| 05/08/2024 | Q1 | $313.5M | $314.5M | $0.23 | $1.15 | -$0.92 |
| 02/21/2024 | Q4 | $395.8M | $389.9M | $1.24 | $2.31 | -$1.06 |
| 11/08/2023 | Q3 | -- | $341M | -$0.67 | -- | -- |
| 08/03/2023 | Q2 | -- | $326M | $0.36 | -- | -- |
| 05/09/2023 | Q1 | -- | $307.1M | -$0.16 | -- | -- |
| 02/15/2023 | Q4 | -- | $396.7M | $1.29 | -- | -- |
| 11/08/2022 | Q3 | -- | $341.9M | $0.39 | -- | -- |
| 08/09/2022 | Q2 | -- | $337.4M | -$0.99 | -- | -- |
| 05/10/2022 | Q1 | -- | $315.1M | $0.51 | -- | -- |
| 02/14/2022 | Q4 | -- | $408.6M | $7.39 | -- | -- |
| 11/03/2021 | Q3 | -- | $355.1M | $0.91 | -- | -- |
| 08/05/2021 | Q2 | -- | $341.3M | $0.35 | -- | -- |
| 03/31/2021 | Q1 | -- | $311.7M | $1.67 | -- | -- |
| 12/31/2020 | Q4 | -- | $384.1M | $1.28 | -- | -- |
| 09/30/2020 | Q3 | -- | $357M | $1.31 | -- | -- |
| 06/30/2020 | Q2 | -- | $331M | $0.80 | -- | -- |
| 03/31/2020 | Q1 | -- | $332.4M | -$0.13 | -- | -- |
| 12/31/2019 | Q4 | -- | $405.6M | $2.45 | -- | -- |
| 09/30/2019 | Q3 | -- | $344.1M | $0.62 | -- | -- |
| 06/30/2019 | Q2 | -- | $322.4M | $0.66 | -- | -- |
| 03/31/2019 | Q1 | -- | $299.9M | $0.66 | -- | -- |
| 12/31/2018 | Q4 | -- | $346.1M | $1.03 | -- | -- |
| 09/30/2018 | Q3 | -- | $292.7M | $0.61 | -- | -- |
| 06/30/2018 | Q2 | -- | $287.9M | $0.57 | -- | -- |
| 03/31/2018 | Q1 | -- | $280.6M | $0.38 | -- | -- |
| 12/31/2017 | Q4 | -- | $316.4M | $1.02 | -- | -- |
| 09/30/2017 | Q3 | -- | $273.6M | $0.66 | -- | -- |
| 06/30/2017 | Q2 | -- | $273.2M | $0.63 | -- | -- |
| 03/31/2017 | Q1 | -- | $254.7M | $0.52 | -- | -- |
| 12/31/2016 | Q4 | -- | $251.8M | $0.89 | -- | -- |
| 09/30/2016 | Q3 | -- | $210.1M | $0.94 | -- | -- |
| 06/30/2016 | Q2 | -- | $211.8M | $0.69 | -- | -- |
| 03/31/2016 | Q1 | -- | $200.5M | $0.61 | -- | -- |
| 12/31/2015 | Q4 | -- | $204.8M | $0.72 | -- | -- |
Ziff Davis, Inc. reported $363.7M worth of top line sales in its most recent quarter.
Ziff Davis, Inc. announced earnings per share of -$0.09 which represents a miss of analyst forecast a $1.78 per share.
Ziff Davis, Inc. reported $253.2M that represents $6.24 per share over the last quarter.
Ziff Davis, Inc.'s earnings are forecast to grow from $1.42 per share to $6.72 per share next year representing an increase of 378.91%.
Ziff Davis, Inc.'s next earnings date is February 23, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.